O
OrbiMed Portfolio holdings
AUM
$3.98B
This Quarter Return
+12.83%
1 Year Return
+13.05%
3 Year Return
+159.74%
5 Year Return
+207.27%
10 Year Return
+1,027.33%
AUM
$10.4B
AUM Growth
+$10.4B
(+9.5%)
Cap. Flow
+$320M
Cap. Flow
% of AUM
3.07%
Top 10 Holdings %
Top 10 Hldgs %
34.73%
Holding
147
New
10
Increased
27
Reduced
30
Closed
6
Top Buys
| 1 |
CMTA
Clementia Pharmaceuticals Inc.
CMTA
|
$176M |
| 2 |
AET
Aetna Inc
AET
|
$80.9M |
| 3 |
Universal Health Services
UHS
|
$74.2M |
| 4 |
IMMU
Immunomedics Inc
IMMU
|
$70.8M |
| 5 |
KALA BIO
KALA
|
$54.3M |
Top Sells
| 1 |
Humana
HUM
|
$185M |
| 2 |
Insmed
INSM
|
$78.6M |
| 3 |
Edwards Lifesciences
EW
|
$49M |
| 4 |
HCA Healthcare
HCA
|
$32.6M |
| 5 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$31.7M |
Sector Composition
| 1 | Healthcare | 91.68% |
| 2 | Financials | 2.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ONC
26
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
| $136M | 1.3% | 1,313,788 +26,200 | +2% | +$2.71M |
|
27
Alnylam Pharmaceuticals
ALNY
$58.5B
| $127M | 1.22% | 1,084,800 +445,600 | +70% | +$52.4M |
|
28
Ascendis Pharma
ASND
$11.8B
| $122M | 1.17% | 3,367,315 | – | – |
|
|
BOLD
29
DELISTED
Audentes Therapeutics, Inc
BOLD
| $116M | 1.11% | 4,129,638 -672,000 | -14% | -$18.8M |
|
30
Viatris
VTRS
$12.3B
| $113M | 1.08% | 3,601,100 +621,900 | +21% | +$19.5M |
|
31
Jazz Pharmaceuticals
JAZZ
$7.75B
| $110M | 1.05% | 749,200 +203,300 | +37% | +$29.7M |
|
32
Select Medical
SEM
$1.61B
| $107M | 1.02% | 5,578,500 +1,891,100 | +51% | +$36.3M |
|
33
Thermo Fisher Scientific
TMO
$186B
| $101M | 0.97% | 534,200 | – | – |
|
|
JUNO
34
DELISTED
Juno Therapeutics, Inc.
JUNO
| $91.6M | 0.88% | 2,041,608 +1,126,400 | +123% | +$50.5M |
|
35
Ironwood Pharmaceuticals
IRWD
$214M
| $90.8M | 0.87% | 5,759,200 | – | – |
|
36
Pfizer
PFE
$141B
| $87.8M | 0.84% | 2,458,800 | – | – |
|
37
Corvus Pharmaceuticals
CRVS
$428M
| $85.7M | 0.82% | 5,379,349 | – | – |
|
38
Illumina
ILMN
$15.8B
| $79.4M | 0.76% | 398,500 | – | – |
|
|
AGN
39
DELISTED
Allergan plc
AGN
| $76.6M | 0.73% | 373,590 | – | – |
|
|
MGLN
40
DELISTED
Magellan Health Services, Inc.
MGLN
| $76.2M | 0.73% | 882,600 -332,500 | -27% | -$28.7M |
|
41
UnitedHealth
UNH
$281B
| $74.4M | 0.71% | 380,000 -48,600 | -11% | -$9.52M |
|
|
GBT
42
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $74.3M | 0.71% | 2,393,635 +221,700 | +10% | +$6.88M |
|
|
43
Universal Health Services
UHS
$11.6B
| $74.2M | 0.71% | +669,000 | New | +$74.2M |
|
|
AERI
44
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $69.9M | 0.67% | 1,438,182 -393,465 | -21% | -$19.1M |
|
45
BioMarin Pharmaceuticals
BMRN
$11.2B
| $69.2M | 0.66% | 743,900 -238,700 | -24% | -$22.2M |
|
46
Medtronic
MDT
$119B
| $68.4M | 0.65% | 879,000 | – | – |
|
|
BLUE
47
DELISTED
bluebird bio
BLUE
| $66.2M | 0.63% | 481,946 +82,146 | +21% | +$11.3M |
|
48
Intellia Therapeutics
NTLA
$1.22B
| $66.2M | 0.63% | 2,662,180 | – | – |
|
|
AGN.PRA
49
DELISTED
Allergan plc.
AGN.PRA
| – | – | 0 | – | – |
|
|
SHPG
50
DELISTED
Shire pic
SHPG
| $61.2M | 0.59% | 399,908 -148,900 | -27% | -$22.8M |
|